BOBI CREEL: Open Payments
NPI 1174866545 · CULLMAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$433 in 23 payments from 12 companies in 2025. Trend: 2023 $511 · 2024 $405 · 2025 $433
Food & beverage: $433
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $74 |
| SANOFI-AVENTIS U.S. LLC | 3 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $59 |
| ABBVIE INC. | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Exact Sciences Corporation | 2 | $31 |
| Biogen, Inc. | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| SANOFI PASTEUR INC. | 1 | $19 |
| Eisai Inc. | 1 | $19 |
Products named: TZIELD, Kerendia, LEQEMBI, UBRELVY, The Cologuard Plus Collection Kit, RECORLEV, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, BREZTRI.
Industry payments across AL — which companies pay providers there.
